Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

2.
3.

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al.

Science. 1994 Jun 17;264(5166):1772-5. Erratum in: Science 1995 Jul 14;269(5221):149.

PMID:
8209258
5.

Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.

Kieran D, Kalmar B, Dick JR, Riddoch-Contreras J, Burnstock G, Greensmith L.

Nat Med. 2004 Apr;10(4):402-5. Epub 2004 Mar 21.

PMID:
15034571
6.

Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Kostic V, Gurney ME, Deng HX, Siddique T, Epstein CJ, Przedborski S.

Ann Neurol. 1997 Apr;41(4):497-504.

PMID:
9124807
7.

Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.

Gurney ME, Cutting FB, Zhai P, Andrus PK, Hall ED.

Pathol Biol (Paris). 1996 Jan;44(1):51-6. Review.

PMID:
8734301
8.
9.

ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury.

Guo Z, Kindy MS, Kruman I, Mattson MP.

J Cereb Blood Flow Metab. 2000 Mar;20(3):463-8.

PMID:
10724110
11.

CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations.

Jaarsma D, Rognoni F, van Duijn W, Verspaget HW, Haasdijk ED, Holstege JC.

Acta Neuropathol. 2001 Oct;102(4):293-305.

PMID:
11603803
12.

[Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].

Aoki M.

Rinsho Shinkeigaku. 2004 Nov;44(11):788-91. Review. Japanese.

PMID:
15651292
13.
14.

Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM, Gurney ME.

Mol Cell Neurosci. 1995 Aug;6(4):349-62.

PMID:
8846004
15.

Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS.

Durham HD, Roy J, Dong L, Figlewicz DA.

J Neuropathol Exp Neurol. 1997 May;56(5):523-30.

PMID:
9143265
16.

Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD.

Shibata N, Hirano A, Kobayashi M, Dal Canto MC, Gurney ME, Komori T, Umahara T, Asayama K.

Acta Neuropathol. 1998 Feb;95(2):136-42.

PMID:
9498047
17.

Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice.

Morrison BM, Janssen WG, Gordon JW, Morrison JH.

J Comp Neurol. 1998 Feb 2;391(1):64-77.

PMID:
9527542
18.

Transgenic mice in the study of ALS: the role of neurofilaments.

Julien JP, Couillard-Despr├ęs S, Meier J.

Brain Pathol. 1998 Oct;8(4):759-69. Review.

PMID:
9804382
19.

The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.

Gonzalez de Aguilar JL, Dupuis L, Oudart H, Loeffler JP.

Biomed Pharmacother. 2005 May;59(4):190-6. Epub 2005 Mar 17.

PMID:
15862714
20.

Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.

Morrison BM, Morrison JH, Gordon JW.

J Exp Zool. 1998 Sep-Oct 1;282(1-2):32-47. Review.

PMID:
9723164

Supplemental Content

Support Center